Literature DB >> 1695201

Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance.

B E Henricson1, W R Benjamin, S N Vogel.   

Abstract

The phenomenon of early endotoxin tolerance, which is induced by sublethal injection of lipopolysaccharide (LPS), results in a protracted period of hyporesponsiveness that is most profound at 3 to 4 days after injection and is marked by reduced cytokine production after a challenge injection of LPS. Early endotoxin tolerance is also induced by the nontoxic LPS derivative monophosphoryl lipid A (MPL), although much more of the monophosphoryl derivative is required to produce a state of tolerance equivalent to that evoked by LPS. In this study, equivalent tolerance-inducing doses of LPS and MPL were tested, and the levels of cytokines induced by LPS and MPL were compared. Although induced levels of colony-stimulating factor were comparable following doses of LPS and MPL that elicited an equivalent state of early endotoxin tolerance, levels of tumor necrosis factor, interleukin-6, and interferon were significantly lower in MPL-injected animals. These results suggest that the lowered toxicity of MPL may be related to its elicitation of significantly lower levels of potentially toxic intermediaries such as tumor necrosis factor, interferon, and interleukin-6.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695201      PMCID: PMC258837          DOI: 10.1128/iai.58.8.2429-2437.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Induction of early-phase endotoxin tolerance in athymic (nude) mice, B-cell-deficient (xid) mice, and splenectomized mice.

Authors:  G S Madonna; S N Vogel
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

2.  Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity.

Authors:  E T Rietschel; H Brade; L Brade; K Brandenburg; U Schade; U Seydel; U Zähringer; C Galanos; O Lüderitz; O Westphal
Journal:  Prog Clin Biol Res       Date:  1987

3.  The role of the liver in the production of fever and in pyrogenic tolerance.

Authors:  C A Dinarello; P T Bodel; E Atkins
Journal:  Trans Assoc Am Physicians       Date:  1968

4.  Early endotoxin tolerance is associated with alterations in bone marrow-derived macrophage precursor pools.

Authors:  G S Madonna; S N Vogel
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

5.  Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes.

Authors:  S N Vogel; E N Kaufman; M D Tate; R Neta
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

6.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

7.  Tumor necrosis factor mediates endotoxic effects in mice.

Authors:  F Bauss; W Dröge; D N Männel
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

8.  Early-phase endotoxin tolerance: induction by a detoxified lipid A derivative, monophosphoryl lipid A.

Authors:  G S Madonna; J E Peterson; E E Ribi; S N Vogel
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

9.  Induction of colony stimulating factor in vivo by recombinant interleukin 1 alpha and recombinant tumor necrosis factor alpha 1.

Authors:  S N Vogel; S D Douches; E N Kaufman; R Neta
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

10.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

View more
  39 in total

1.  Trehalose 6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis induces corneal angiogenesis in rats.

Authors:  N Saita; N Fujiwara; I Yano; K Soejima; K Kobayashi
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 2.  Biochemical transformation of bacterial lipopolysaccharides by acyloxyacyl hydrolase reduces host injury and promotes recovery.

Authors:  Robert S Munford; Jerrold P Weiss; Mingfang Lu
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

3.  An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance.

Authors:  B E Henricson; R Neta; S N Vogel
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

4.  Roles of interleukin-1 and tumor necrosis factor in lipopolysaccharide-induced hypoglycemia.

Authors:  S N Vogel; B E Henricson; R Neta
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

5.  IRAK4 kinase activity is not required for induction of endotoxin tolerance but contributes to TLR2-mediated tolerance.

Authors:  Yanbao Xiong; Meghan Pennini; Stefanie N Vogel; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2013-05-21       Impact factor: 4.962

6.  Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.

Authors:  Leah E Cole; Barbara J Mann; Kari Ann Shirey; Katharina Richard; Yang Yang; Patricia J Gearhart; Kirsty L Chesko; Rose M Viscardi; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2011-07-12       Impact factor: 4.962

7.  Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase.

Authors:  Kathryn T Chen; Madhu S Malo; Angela K Moss; Skye Zeller; Paul Johnson; Farzad Ebrahimi; Golam Mostafa; Sayeda N Alam; Sundaram Ramasamy; H Shaw Warren; Elizabeth L Hohmann; Richard A Hodin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-05-20       Impact factor: 4.052

8.  Monophosphoryl Lipid A: A Novel Agent for Inducing Pharmacologic Myocardial Preconditioning.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

9.  Differential myelopoietic responsiveness of BALB/c (Itys) and C.D2 (Ityr) mice to lipopolysaccharide administration and Salmonella typhimurium infection.

Authors:  V M Peterson; G S Madonna; S N Vogel
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  Differential regulation of cytokine production in lipopolysaccharide tolerance in mice.

Authors:  A Erroi; G Fantuzzi; M Mengozzi; M Sironi; S F Orencole; B D Clark; C A Dinarello; A Isetta; P Gnocchi; M Giovarelli
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.